Biotek-snakken

	27/9 06:19 af ProInvestorNEWS	AstraZeneca scores wider US lung cancer label for Tagrisso (link)
	27/9 06:18 af ProInvestorNEWS	AbbVie sets sights on clinical hat trick for Cerevel Parkinson's drug (link)
	27/9 05:42 af ProInvestorNEWS	SEC Announces $40 Mln Settlement With Cassava Sciences Over Misleading Alzheimer's Trial Statements (link)
	27/9 05:33 af ProInvestorNEWS	Evaxion sælger rettigheder til to vaccinekandidater for potentielt milliardbeløb Det er partneren MSD, som køber retten til en vaccinekandidat mod gonoré og et ikke-offentliggjort infektionsmiddel. (Medwatch abonnement) (link)
	27/9 05:32 af ProInvestorNEWS	Evaxion significantly expands vaccine development collaboration with MSD (link)
	27/9 05:19 af ProInvestorNEWS	Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment (link)
	27/9 05:18 af ProInvestorNEWS	Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up (link)
	27/9 05:17 af ProInvestorNEWS	Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up (link)
	27/9 04:36 af Fandel	Godmorgen...
	25/9 07:20 af exitnu	SEB inleder bevakning på Genovis med köp och riktkurs 30 kronor - BN /Finwire
	23/9 14:30 af exitnu	Genovis Launches FabRICATOR® Xtra: Next-Generation Enzyme for Future Antibody Therapeutics (link)
	23/9 06:18 af ProInvestorNEWS	Sanofi gears up to seek approval of BTK inhibitor tolebrutinib in MS (link)
	23/9 06:16 af ProInvestorNEWS	FDA greenlights Sanofi's Sarclisa in frontline multiple myeloma (link)
	23/9 04:28 af Fandel	Godmorgen...
	21/9 07:25 af ProInvestorNEWS	FDA Approves Zevra Therapeutics' MIPLYFFA For Treatment Of Niemann-Pick Disease Type C (link)
	21/9 04:32 af Fandel	Godmorgen...
	20/9 05:01 af ProInvestorNEWS	Ascendis Pharma Prices Public Offering Of 2 Mln ADSs At $150.00/ADS (link)
	20/9 05:00 af ProInvestorNEWS	Tectonic Therapeutics Announces Positive Phase 1a Results For TX45 In Treating Group 2 PH-HFpEF (link)
	20/9 05:00 af ProInvestorNEWS	ELAN : FDA Oks Zenrelia, Once-Daily Oral JAK Inhibitor For Dogs With Allergic And Atopic Dermatitis (link)
	19/9 17:37 af Henrikhot	(link) Saniona Receives Regulatory Approval for SAN711 Biomarker Study
	19/9 17:34 af Henrikhot	Saniona kommenterar godkännandet att inleda epilepsistudie (link)
	19/9 08:39 af exitnu	"Handel i betalda tecknade units (”BTU”): 20 augusti – 20 september 2024."
	19/9 08:38 af exitnu	Ascelia Pharma BTU: sidste handelsdag nu på fredag :-)
	19/9 05:03 af ProInvestorNEWS	Incyte: Phase 2 Trial Results Of Niktimvo In Chronic Graft-Versus-Host Disease Meet Primary Goal (link)

	17/9 05:11 af ProInvestorNEWS	I-Mab Reports Promising Results From Phase 1 Study Of Givastomig In Gastric Cance (link)
	16/9 10:14 af ProInvestorNEWS	Johnson & Johnson Reports Promising Interim Data From Phase 2 SunRISe-4 Study (link)
	16/9 07:38 af exitnu	"På våra prognoser och antagande om teckning av optionsprogrammet bedömer vi att Ascelia kommer att klara sig omkring 18-24 månader innan ytterligare kapital eventuellt kommer behöva skjutas till."
	16/9 07:37 af exitnu	Penser Access & Future by Carnegie: Ascelia Pharma: Kassan fylld (link) Aktiekurs 2,1 kr - Motiverat värde 5,0 - 7,0 kr.
	14/9 11:31 af ProInvestorNEWS	Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? (link)
	14/9 11:29 af ProInvestorNEWS	Sutro Announces Updated Data From Phase 1b Study Of Luvelta Combination In Epithelial Ovarian Cancer (link)
	14/9 10:49 af ProInvestorNEWS	Bicycle Therapeutics Reveals Updated Clinical Results Across Oncology Pipeline(link)
	14/9 10:48 af ProInvestorNEWS	Pfizer's BRAFTOVI + MEKTOVI Delivers Long-Term Benefits In BRAF V600E-Mutant NSCLC (link)
	14/9 09:43 af bibob	Ascelia Pharma. (link)
	14/9 05:55 af Fandel	Godmorgen...
	13/9 21:36 af Occam	Ja. Det ville være finere, hvis investorerne var mere ligestillede ift. informationer. - Nå, Biontech sluttede dagen med +17,5%, hele ugen med +33,5%.
	13/9 20:00 af peter12	Der er gange i flere biotek i aften pga ESMO (link)
	13/9 16:46 af Occam	Biontech +11% på Nasdaq. Efter to timer er omsætningen 4 gange en normal dags.
	13/9 13:36 af exitnu	Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients (link)
	13/9 13:35 af exitnu	Moberg Pharma nede med minus 57% i dag ...
	13/9 05:36 af ProInvestorNEWS	Cidara Eliminates 30% Of Workforce To Prioritize Clinical Development Of CD388; Stock Down (link)
	13/9 05:26 af ProInvestorNEWS	Immuneering Reports Positive Initial Data For IMM-1-104 In Phase 2a Pancreatic Cancer Trial;stock Up (link)
	13/9 05:24 af ProInvestorNEWS	FDA Oks Genentech's Tecentriq Hybreza As First & Only Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy (link)
	13/9 05:02 af Fandel	Godmorgen...
	13/9 04:49 af Helge Larsen/PI-redaktør	Godmorgen :-)
	12/9 13:19 af Aps invest	Board member purchases shares in Acarix I dag kl. 14:02 ∙ MFN Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Dr. Tony Daz, Board member of Acarix, purchased 2,000,600 shares in the company between September 9 and September 11 at an average price of USD 0.031 per share. His total ownership amounts to 2,000,600 shares. "I have great faith in the company and its product. The Acarix system is a disruptive technology to rapidly rule out CAD in a cost-effective way and
	12/9 05:04 af ProInvestorNEWS	J&J's TREMFYA Receives FDA Approval For Moderately To Severely Active Ulcerative Colitis In Adults (link)
	12/9 05:03 af ProInvestorNEWS	Ascendis Pharma Gets U.S. Orphan Drug Exclusivity For YORVIPATH In Adult Hypoparathyroidism (link)
	12/9 05:03 af ProInvestorNEWS	Innovent Biologics : Phase 3 Trial Results Of Mazdutide In Type 2 Diabetes Presented At EASD 2024 (link)
	12/9 05:00 af Helge Larsen/PI-redaktør	Godmorgen :-)
	11/9 06:31 af LP90	Godmorgen :-)